NSRX (NYSEAMERICAN:NSRX) Given New $18.00 Price Target at Citizens Jmp

NSRX (NYSEAMERICAN:NSRX) had its price target cut by Citizens Jmp from $19.00 to $18.00 in a report issued on Thursday,Benzinga reports. They currently have a market outperform rating on the stock.

NSRX Price Performance

NSRX stock opened at $2.40 on Thursday. The business has a 50-day moving average of $5.01. NSRX has a fifty-two week low of $2.29 and a fifty-two week high of $9.99.

NSRX Company Profile

Nasus Pharma Ltd. is a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions. Nasus Pharma Ltd. is based in TEL AVIV, Israel.